Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (7): 43-47.doi: 10.6040/j.issn.1671-7554.0.2022.0166

Previous Articles     Next Articles

Treatment of adenomyosis complicated with infertility

YAN Lei, CHEN Zijiang   

  1. Department of Gynecology, Center for Reproductive Medicine, Shandong University, Jinan 250021, Shandong, China
  • Published:2022-07-27

RichHTML

1

PDF (PC)

238

Abstract: Adenomyosis can cause infertility and miscarriage, increase the miscarriage rate of in vitro fertilization intracytoplasmic sperm injection and embryo transfer(IVF-ET), reduce the live birth rate and clinical pregnancy rate, and increase obstetric and neonatal complications. Transvaginal ultrasound has become the first-line diagnostic method of adenomyosis, but the accuracy needs to be improved. The treatment of adenomyosis complicated with infertility includes drug, surgical, interventional therapy and assisted reproduction therapy, et al. IVF is generally recommended as the first choice, and GnRH-a and freeze-all strategy are also recommended. More research is needed to explore the diagnosis of adenomyosis, efficacy of non-IVF treatment, pretreatment of GnRH-a, and comparison of fresh versus frozen embryo transplantation.

Key words: Adenomyosis, Infertility, In vitro fertilization intracytoplasmic sperm injection, Embryo transfer

CLC Number: 

  • R711.74
[1] Megan L, Tammy YC, Keith BI. A systematic review of adenomyosis: it is time to reassess what we thought we knew about the disease [J]. J Minim Invasive Gynecol, 2021, 28(3): 644-655.
[2] Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis [J]. Fertil Steril, 2017, 108(3): 483-490.
[3] Mehasseb MK, Bell SC, Brown L, et al. Phenotypic characterisation of the inner and outer myometrium in normal and adenomyotic uteri [J]. Gynecol Obstet Invest, 2011, 71(4): 217-224.
[4] Fischer CP, Kayisili U, Taylor HS. HOXA10 expressionis decreased in endometrium of women with adenomyosis [J]. Fertil Steril, 2011, 95(3): 1133-1136.
[5] Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms [J]. Reprod Biomed Online, 2017, 35(5): 592-601.
[6] 王冰玉, 杨阳, 晁岚. TOLL 样受体 4 在 15 例子宫腺肌病中的表达及作用[J]. 山东大学学报(医学版), 2020, 58(6): 47-52. WANG Bingyu, YANG Yang, CHAO Lan. Expression and role of toll-like receptor 4 in adenomyosis[J]. Journal of Shandong university(Health Sciences), 2020,58(6):47-52.
[7] Mavrelos D, Holland TK, ODonovan O, et al. The impact of adenomyosis on the outcome of IVF-embryo transfer [J]. Reprod Biomed Online, 2017, 35(5): 549-554.
[8] Martínez-Conejero JA, Morgan M, Montesinos M, et al. Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation [J]. Fertil Steril, 2011, 96(4): 943-950.
[9] Yan L, Ding L, Tang R, et al. Effect of adenomyosis on in vitro fertilization/intracytoplasmic sperm injection outcomes in infertile women: a retrospective cohort study [J]. Gynecol Obstet Invest, 2014, 77(1): 14-18.
[10] Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis [J]. Reprod Biomed Online, 2021, 42(1): 185-206.
[11] Cozzolino M, Tartaglia S, Pellegrini L, et al. The effect of uterine adenomyosis on IVF outcomes: a systematic review and meta-analysis [J]. Reprod Sci, 2022, 3. doi: 10.1007/s43032-021-00818-6.
[12] 子宫腺肌病伴不孕症诊疗中国专家共识编写组. 子宫腺肌病伴不孕症诊疗中国专家共识[J]. 中华生殖与避孕杂志, 2021, 41(4): 287-295.
[13] 中国医师协会妇产科医师分会子宫内膜异位症专业委员会. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6): 376-383.
[14] Zhang XP, Zhang YF, Shi R, et al. Pregnancy outcomes of infertile women with ultrasound-diagnosed adenomyosis for in vitro fertilization and frozen-thawed embryo transfer [J]. Arch Gynecol Obstet, 2021, 304(4): 1089-1096.
[15] Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis [J]. Fertil Steril, 2018, 109(3): 389-397.
[16] Megan L, Tammy YC, Keith BI. A systematic review of adenomyosis: it is time to reassess what we thought we knew about the disease [J]. J Minim Invasive Gynecol, 2021, 28(3): 644-655.
[17] 盛燕霞, 马彩虹, 杨蕊, 等.不同控制促排卵方案对子宫腺肌病患者体外受精胚胎移植结局的影响[J]. 生殖与避孕, 2010, 30(6): 375-378.
[18] Hou X, Xing J, Shan H, et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment [J]. Reprod Biomed Online, 2020, 41(5): 845-853.
[19] Rocha TP, Andres MP, Borrelli GM, et al. Fertility-sparing treatment of adenomyosis in patients with infertility: a systematic review of current options [J]. Reprod Sci, 2018, 25(4): 480-486.
[20] Thalluri V, Tremellen KP. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment [J]. Hum Reprod, 2012, 27(12): 3487-3492.
[21] Lan J, Wu YQ, Wu ZX, et al. Ultra-long GnRH agonist protocol during IVF/ICSI improves pregnancy outcomes in women with adenomyosis: a retrospective cohort study [J]. Front Endocrinol(Lausanne), 2021, 12: 609771. doi:10.3389/fendo.2021.609771.
[22] Li M, Xu L, Zhao H, et al. Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis [J]. Sci Rep, 2021, 11(1): 19326.
[23] Chen M, Luo L, Wang Q, et al. Impact of gonadotropin-releasing hormone agonist pre-treatment on the cumulative live birth rate in infertile women with adenomyosis treated with IVF/ICSI: a retrospective cohort study [J]. Front Endocrinol(Lausanne), 2020, 11: 318. doi:10.3389/fendo.2020.00318.
[24] Ghobara T, Gelbaya TA, Ayeleke RO. Cycle regimens for frozen-thawed embryo transfer [J]. Cochrane Database Syst Rev, 2017, 7: CD003414
[25] Fábregues F, Balasch J, Creus M, et al. Long-term down-regulation does not improve pregnancy rates in an in vitro fertilization program [J]. Fertil, Steril, 1998, 70(1): 46-51.
[26] Liang Z, Yin M, Ma M, et al. Effect of pretreatment with a levonorgestrel releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis [J]. Reprod Biomed Online, 2019, 39(1): 111-118.
[27] Yun BH, Jeon YE, Seo SK, et al. Effects of a levonorgestrel-releasing intrauterine system on the expression of steroid receptor coregulators in adenomyosis [J]. Reproductive sciences, 2015, 22(12): 1539-1548.
[28] Gomes MK, Rosa-e-Silva JC, Garcia SB, et al. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium [J]. Human reproduction, 2009, 24(11): 2736-2745.
[29] Tan J, Moriarty S, Taskin O, et al. Reproductive outcomes after fertility-sparing surgery for focal and diffuse adenomyosis: a systematic review [J]. J Minim Invasive Gynecol, 2018, 25(4): 608-621.
[30] Wu YC, Huang JY, Zhong GZ, et al. Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis [J]. Reprod Biomed Online, 2022, 44(2): 380-388.
[31] Wei D, Liu JY, Sun Y, et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial [J]. Lancet, 2019, 393(10178): 1310-1318.
[32] Zhu XW, Dongye HJ, Lu SM, et al. Pregnancy outcomes after fresh versus frozen embryo transfer in women with adenomyosis: a retrospective cohort study [J]. Reprod Biomed Online, 2022, 44(6):1023-1029.
[1] Guoyun WANG,Zangyu PAN. Research progress of animal models of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 48-55.
[2] Guowei TAO,Fang WANG,Xiangyi DONG,Yaxuan XU,Linli ZHAO,Beibei HU. Diagnosis of adenomyosis using ultrasound and magnetic resonance imaging [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 56-65.
[3] AILI Aixingzi, GUO Zhengyu, ZHANG Xiaofei. Latest research advances of high intensity focused ultrasound treatment for adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 36-42.
[4] YI Xiaofang, HUANG Jihua. Patient education and proper management of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 32-35.
[5] ZHANG Xinmei, XU Ping. Surgical treatment strategies of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 26-31.
[6] LENG Jinhua, SHI Jinghua. Clinical manifestations of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 1-5.
[7] PENG Chao, ZHOU Yingfang. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25.
[8] GUO Sunwei, LIU Xishi. Cracking the enigma of pathogenesis and pathophysiology of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 6-19.
[9] WU Richao, LIU Hong, WANG Ze, GAO Shanshan, LI Xiufang, SHI Yuhua. Pregnancy outcomes of in vitro fertilization-intracytoplasmic sperm injection-embryo transfer in women 40 years and above [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 35-39.
[10] XU Ge, LI Qing, ZHANG Cancan, TIAN Yongjie. Expressions and clinical significance of PARP-1 and HIF-1α in adenomyosis tissues and primary cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 55-61.
[11] SHI Yuhua, WANG Qiumin, QI Dan. Frontier research hotspot and progress in assisted reproductive technology [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 97-102.
[12] DENG Xiaohui, GUO Ling. Applications and progress of immunotherapy in repeated implantation failure [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 32-37.
[13] SHAN Jing, WANG Xiaoqiu, LI Dajin. Molecular mechanisms of NK cells involved in endometriosis and its associated infertility [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 8-13.
[14] WU Xiaolin, LI Ping. Effect of Gn stimulation duration on pregnancy outcome of IVF-ET in long GnRHa protocol [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 32-37.
[15] GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan. Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 79-86.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1 -6 .
[2] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32 -37 .
[3] LONG Tingting, XIE Ming, ZHOU Lu, ZHU Junde. Effect of Noggin protein on learning and memory abilities and the dentate gyrus structure after cerebral ischemia reperfusion injury in mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 15 -23 .
[4] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38 -46 .
[5] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7 -14 .
[6] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24 -31 .
[7] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67 -71 .
[8] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60 -66 .
[9] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
[10] GUO Zhihua, ZHAO Daqing, XING Yuan, WANG Wei, LIANG Leping, YANG Jing, ZHAO Qianqian. Single-stage end-to-end anastomosis in the management of severe cervical tracheal stenosis[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 72 -76 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd